Wuxi PharmaTech (Cayman), Inc.

( )
WX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.45%178.890.7%$1413.67m
PFEPfizer Inc. 1.40%51.380.9%$1340.95m
ABBVAbbVie, Inc. -0.44%154.791.9%$1186.63m
BMYBristol-Myers Squibb Co. 1.73%78.241.0%$1172.57m
MRKMerck & Co., Inc. 0.85%93.100.7%$1086.85m
LLYEli Lilly & Co. 0.70%301.481.1%$869.46m
AZNAstraZeneca Plc 1.78%65.641.0%$490.27m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.64%141.500.0%$430.00m
VERUVeru, Inc. 15.56%15.600.0%$382.60m
GSKGlaxoSmithKline Plc 0.78%44.720.2%$223.61m
NVSNovartis AG 0.13%87.930.2%$221.04m
HZNPHorizon Therapeutics Plc 2.29%92.905.4%$202.12m
SGENSeagen Inc. 2.81%146.555.7%$174.63m
NVONovo Nordisk A/S 3.02%106.360.1%$174.32m
CTLTCatalent, Inc. 3.17%100.772.0%$156.47m

Company Profile

Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China.